What happens when you take fisetin with quercetin?
Fisetin and quercetin are closely related flavonols found in everyday foods such as strawberries, apples, onions, and capers. Both have antioxidant and anti-inflammatory activity, and both are studied in longevity research as candidate senolytics — compounds that may help clear 'senescent' cells, the worn-out, non-dividing cells that build up with age and release inflammatory signals (the senescence-associated secretory phenotype, or SASP). When you take them together, here is what is going on:
- Two related flavonols enter the same pathways. Fisetin and quercetin share a similar chemical backbone, so they act on overlapping targets rather than entirely separate ones.
- They scavenge free radicals and dampen inflammation. Both have general antioxidant activity and can reduce activity of inflammatory signalling such as NF-kB.
- They nudge the same survival switches in aged cells. In laboratory studies both interact with BCL-2-family anti-apoptotic proteins that senescent cells lean on to stay alive.
- The combined effect is mostly additive, not a dramatic new effect. Because their mechanisms overlap rather than complement each other neatly, stacking them broadens coverage modestly — it does not reliably multiply the benefit.
It is worth being precise about the evidence here. A 2018 screen from the Mayo Clinic group, published in EBioMedicine, identified fisetin as the most potent natural senolytic among the flavonoids tested — but that study examined fisetin alone in cells and mice, not a fisetin-plus-quercetin combination. The best human senolytic data come from a different protocol: the prescription drug dasatinib paired with quercetin. The popular consumer pairing of fisetin with quercetin has not been validated in robust human trials.
Why is this important?
This pairing matters mainly because of how it is marketed versus what the evidence actually shows. Senescent-cell accumulation has been linked to age-related declines in tissue function, frailty, and chronic inflammation, and clearing those cells in animal models has improved physical function and healthspan. That is a genuinely interesting research direction.
But the leap from animal data to a specific consumer flavonoid stack is large. The human senolytic trials — in conditions such as diabetic kidney disease and idiopathic pulmonary fibrosis — tested dasatinib plus quercetin, a regimen that includes a prescription chemotherapy drug. Most people will never take dasatinib, so natural-only stacks built around fisetin and quercetin are a consumer-friendly approximation of the senolytic idea, not a tested equivalent. The reasonable takeaway: this is a low-risk, well-tolerated flavonoid combination with plausible mechanisms, but you should treat its anti-aging claims as preliminary rather than proven, and keep expectations modest.
What should you do?
Because this combination is low-severity but not strongly evidence-backed for the specific pairing, the sensible approach is to keep it simple, take it for absorption, and review it with a professional if you take other medicines.
Before you start (or change anything):
- Review the plan with your doctor or pharmacist if you take any prescription medication — both flavonoids can modestly affect platelet aggregation and the metabolism of certain drugs (including blood thinners and some statins).
- If you take a blood thinner, immunosuppressant, or a drug with a narrow safety margin, get explicit clearance before adding either flavonoid.
- Set realistic expectations: the strong human senolytic data are for a prescription combination, not this pair.
Every day you take them:
- Take both with a fat-containing meal, since flavonoid absorption improves with dietary fat.
- Stick to the labelled serving on whatever product you use rather than escalating amounts in search of a stronger 'senolytic' effect.
- Note how you feel; stop and reassess if anything seems off, especially unusual bruising or bleeding.
After any change — new medication, surgery, or a new health condition:
- Pause the stack ahead of any planned surgery or procedure and tell your care team you have been taking flavonoid supplements, because of the modest effect on platelets.
- Re-check the combination with your pharmacist whenever a new prescription is added.
Which specific products are affected?
This applies to any product or routine that combines fisetin and quercetin, whether in one capsule or taken separately.
- Standalone fisetin capsules
- Liposomal fisetin formulations (marketed for better absorption)
- Quercetin dihydrate, often with bromelain or vitamin C added
- Quercetin phytosome formulations (e.g. Quercefit)
- 'Senolytic' blends that combine fisetin, quercetin, and resveratrol in a single capsule
Both flavonoids also occur naturally in foods such as strawberries, apples, onions, and capers, though at far lower amounts than in supplements.
The science behind it
The evidence base for this pairing is narrower than the marketing suggests, so it is worth seeing exactly what the key studies tested.
The most cited reference is Yousefzadeh and colleagues (EBioMedicine, 2018), which screened a panel of flavonoids and found fisetin to be the most potent senolytic among them, extending health and lifespan in mice. Crucially, this was an in-vitro and mouse study of fisetin on its own — it does not establish a benefit for the fisetin-plus-quercetin combination, and it is not a human trial.
The human senolytic literature centres on dasatinib plus quercetin in small pilot and longitudinal studies (for example in diabetic kidney disease and idiopathic pulmonary fibrosis), with mixed but encouraging early results. A 2024 longitudinal study indexed at PMC10929829 (Lee and colleagues, Aging) tracked DNA-methylation aging clocks in people taking dasatinib and quercetin, with and without added fisetin — but quercetin still appears there as the partner to a prescription drug, not as a tested fisetin-plus-quercetin pairing on its own.
In short: fisetin alone has supportive animal evidence, quercetin has human evidence only in combination with dasatinib, and the specific fisetin-plus-quercetin pairing sold to consumers has no robust human trial behind it. The mechanistic rationale is reasonable; the clinical proof for this exact combination is not yet there.
- Yousefzadeh MJ, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018. (PMC6197652)
- Lee E, et al. Exploring the effects of Dasatinib, Quercetin, and Fisetin on DNA methylation clocks: a longitudinal study on senolytic interventions. Aging (Albany NY). 2024. (PMC10929829)
Frequently Asked Questions
Is it dangerous to take fisetin and quercetin together?
For most healthy people the combination is low-risk and generally well tolerated. The main caution is that both can modestly affect platelet function and the metabolism of some drugs, so the safety question is really about your other medications rather than the pair itself.
Does taking both work better than taking one?
Possibly a little, but do not count on a big effect. Their mechanisms overlap rather than complement each other, so combining them broadens coverage modestly rather than multiplying the benefit. There is no robust human trial showing the pair outperforms either one alone.
Isn't this the same as the proven 'senolytic' protocol?
No. The human senolytic trials used dasatinib (a prescription drug) plus quercetin. A fisetin-plus-quercetin stack is a natural-only approximation of that idea, not the tested regimen, and it has not been validated in people.
When and how should I take them?
Take both with a meal that contains some fat, since these flavonoids absorb better with dietary fat. Follow the serving on the product label rather than escalating amounts.
Can I take them with my prescription medications?
Check first. Because both flavonoids can affect platelet aggregation and certain drug-metabolising enzymes, review the combination with your doctor or pharmacist before adding it to blood thinners, immunosuppressants, statins, or any narrow-margin medication.
Should I stop before surgery?
Yes, it is sensible to pause ahead of any planned surgery or procedure and tell your care team you have been taking flavonoid supplements, given their mild effect on platelets.
Key takeaways
- Fisetin and quercetin are related dietary flavonols with overlapping antioxidant, anti-inflammatory, and candidate-senolytic activity.
- The strong human senolytic evidence is for dasatinib plus quercetin — the fisetin-plus-quercetin pairing rests on animal and mechanistic data, with no robust human trial.
- Combining them is low-risk and mostly additive; treat anti-aging claims as preliminary and keep expectations modest.
- Take both with a fat-containing meal for better absorption.
- Both can modestly affect platelet function and drug metabolism — review with your doctor or pharmacist before combining with any prescription medicine, and pause before surgery.